Tessa DeCarbo is a Territory Manager specializing in Structural Heart, focusing on TAVI/TAVR. With extensive experience in pharmaceutical sales, Tessa has led high-performing teams at Salix Pharmaceuticals, contributing to the growth of the Xifaxan brand, and received numerous accolades, including the Presidents Club award. At Abbott, Tessa developed the MitraClip therapy market, ranking first in the nation for volume growth. Currently, Tessa ranks fourth in the U.S. for revenue performance in their role within Structural Heart.
This person is not in the org chart
This person is not in any teams
This person is not in any offices